Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-133785

SVP, Chief Business Officer sold 27,500 shares at $5.00 ($137,500)

  • SVP, Chief Business Officer acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan SVP, Chief Business Officer 2021-11-01 Option exercise +27,500 $0.92 $25,300 44,667 D
Korbel Gregory Alan SVP, Chief Business Officer 2021-11-01 Sale −27,500 $5.00 $137,500 17,167 D
Derivatives
Korbel Gregory Alan SVP, Chief Business Officer 2021-11-01 Option exercise · Stock Option (right to Buy) −25,245 0 D
Korbel Gregory Alan SVP, Chief Business Officer 2021-11-01 Option exercise · Stock Option (right to Buy) −2,255 29,835 D
Open-market sales · 27,500 sh · avg $5.00 · $137,500
Loading xslF345X03/tm2131764-1_4seq1.xml…